Picture of DXS International logo

DXSP — DXS International News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Notice of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231106:nGNE1KkMZS&default-theme=true


DXS INTERNATIONAL PLC

Notice of 2023 Annual General Meeting

The Board of DXS International plc (the “Company”), the AQSE Growth Market
quoted clinical decision support developer and supplier of clinical decision
support systems, confirms that its Annual General Meeting is scheduled to take
place on Thursday 30th November 2023 at Noon at the Pavilion Café, Tanshire
Park, Shackleford Road, Elstead, Surrey GU8 6LB.

For further information in relation to the AGM, shareholders should refer to
the Notice of Annual General Meeting and the AGM Letter which have been
despatched to shareholders. Copies of these documents, along with the
Company's Annual Report for the year ended 30 April 2023, are available for
download from the Company's website www.dxs-system.co.uk .

The Directors of DXS International plc accept responsibility for this
announcement

Enquiries:

 David Immelman (Chief Executive) DXS International plc                                   01252 719800 david@dxs-systems.com  
 Suite 2, Second Floor Ash House, Tanshire Park Shackleford Road Elstead, Surrey GU8 6LB                                      
 www.dxs-systems.co.uk                                                                                                        



 Corporate Advisor                              
 David Papworth City & Merchant  0207 101 7676  



 Corporate Broker                                 
 Hybridan LLP Claire Louise Noyce  020 3764 2341  

Note to Editors:

DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other trusted NHS
sources, to doctors, nurses and pharmacists in their workflow and during the
patient consultation. This effective clinical decision support ultimately
translates to improved healthcare outcomes delivered more cost effectively
which should significantly contribute towards the NHS achieving its projected
efficiency savings

Recent news on DXS International

See all news